According to an advance edition of the New England Journal of Medicine, a new type of medicine for type 1 diabetes could prove effective. The new treatment, administered by injectio, is called GAD-alum.
GAD-alum specifically targets an individual protein called GAD. Amongst people with type 1 diabetes, GAD is part of the way in which the immune system attacks the pancreas . By curbing GAD, researcher believe the insulin -producing cells in the pancreas could be saved.
A study conducted in Sweden at Linkoping University tested GAD-alum treatment and found that whilst it did not cure type 1 diabetes, the rate of decline in pancreatic cells slowed somewhat. Although GAD-alum testing appears safe, the researchers noted that further research was needed. The study was done using grants from Diamyd Medical .

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…